SCHEMBL5698609

SCHEMBL5698609

NNC(=O)C(=Cc1ccccc1)OCO

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.42
KMT2A Q03164 5/20 0.42
ABCG2 Q9UNQ0 1/20 0.40
LMNA P02545 2/20 0.39
PLIN1 O60240 1/20 0.39
PLIN5 Q00G26 1/20 0.39
ABHD5 Q8WTS1 1/20 0.39
RECQL P46063 1/20 0.39
ALDH1A1 P00352 4/20 0.39
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 4/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
MME P08473 2/20 0.38
NFKB1 P19838 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1695603 0.81 ABCG2 (0.56) MEN1KMT2AABCG2LMNARECQL
SCHEMBL1695601 0.81 ABCG2 (0.56) MEN1KMT2AABCG2LMNARECQL
SCHEMBL528920 0.81 MEN1 (0.49) MEN1KMT2ALMNARECQLALDH1A1
SCHEMBL28182392 0.75 MEN1 (0.41) MEN1KMT2AABCG2LMNARECQL
SCHEMBL11479641 0.70 AKR1C3 (0.62) MEN1KMT2ARECQLALDH1A1RAB9A
SCHEMBL11479639 0.70 AKR1C3 (0.62) MEN1KMT2ARECQLALDH1A1RAB9A
SCHEMBL11476503 0.69 MAPT (0.69) MEN1KMT2ALMNAALDH1A1POLB
SCHEMBL11476504 0.69 MAPT (0.69) MEN1KMT2ALMNAALDH1A1POLB
SCHEMBL25222059 0.69 KMT2A (0.55) MEN1KMT2ALMNAALDH1A1RAB9A
SCHEMBL11026391 0.68 ABCG2 (0.56) MEN1KMT2AABCG2LMNARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682143-A2 COMBINATIONS COMPRISING AN HSP90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA Pharmacia Corporation (US) 2006-07-26 EP disclosed
WO-2005044194-A2 TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR PHARMACIA CORPORATION (US) 2005-05-19 WO disclosed
WO-2005041879-A2 COMBINATIONS COMPRISING AN Hsp90 INHIBITOR AND A PHOPHODIESTERASE INHIBITOR FOR TREATING OR PREVENTING NEOPLASIA PHARMACIA CORPORATION (US) 2005-05-12 WO disclosed